TSCAN THERAPEUTICS INC
TCRXNASDAQ🏆 #3670 by market capUS Equity
$0.78▲ $0.01 (+1.28%)
Market closed · at close1h—
24h▲ 1.3%
7d▼ 0.4%
14d▲ 4.4%
30d▼ 24.2%
1y▼ 53.3%
🏦Market Cap
$51M
Small Cap
📈Revenue Growth (YoY)
+106.7%
High Growth
📊Gross Margin
—
💵FCF Margin
—
⚖️P/S Ratio
5.5x
Fair
Otter Score
59
Weak
📊
Analyst Ratings
Price
$0.7768
Total
8
Raised
0
Lowered
1
Avg PT
$7.50
H / L
$12 / $3
| Institution | Action | Rating | Date |
|---|---|---|---|
Wedbush | Reiterated | Outperform | 2026-06-23 |
Needham | Reiterated | Buy | 2026-06-23 |
HC Wainwright & Co. | Reiterated | Buy | 2025-11-13 |
BTIG | Downgraded | Buy → Neutral | 2025-11-04 |
Barclays | Reiterated | Overweight | 2025-03-07 |
Cowen & Co. | Reiterated | Outperform | 2021-08-13 |
Jefferies | Reiterated | Buy | 2021-08-10 |
Morgan Stanley | Reiterated | Overweight | 2021-08-10 |
One row per institution, most recent rating